A Single-Centre, Open Label, Single-Dose, Four Parallel Cohorts Study to Investigate the Pharmacokinetics, Safety and Tolerability of SB-649868 [GSK-649868] 10mg in Healthy Female 'Non-Childbearing Potential', Healthy Male and in Healthy Elderly Subjects.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2015
At a glance
- Drugs GSK 649868 (Primary)
- Indications Insomnia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 11 Jun 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 01 Nov 2007 New trial record.